Trisalus Life Sciences Inc (TLSI)

01:44 AM

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives $11.56 Average Price Target from Analysts - Defense World

01:44 AM

Apr 15, 2025

TriSalus Life Sciences, Inc. SEC 10-K Report - TradingView

Apr 15, 2025

Apr 09, 2025

TriSalus Life Sciences, Inc. (TLSI) Soars 6.6%: Is Further Upside Left in the Stock? - Nasdaq

Apr 09, 2025

Apr 01, 2025

Uveal Neoplasms Treatment Market Size in 7MM is expected to grow - openPR.com

Apr 01, 2025

Mar 31, 2025

TriSalus Life Sciences (TLSI) Expected to Announce Quarterly Earnings on Monday - Defense World

Mar 31, 2025

Mar 31, 2025

TriSalus Life Sciences, Inc. (TLSI) Reports Q4 Loss, Tops Revenue Estimates - MSN

Mar 31, 2025

Mar 30, 2025

TriSalus Life Sciences Reports Strong Growth Amid Challenges - MSN

Mar 30, 2025

Mar 30, 2025

Canaccord Genuity Group Reiterates Buy Rating for TriSalus Life Sciences (NASDAQ:TLSI) - Defense World

Mar 30, 2025

Mar 30, 2025

TriSalus Life Sciences: Optimistic Guidance For 2025, But There Are Still Risks - Seeking Alpha

Mar 30, 2025

Mar 29, 2025

TriSalus Life Sciences’ (TLSI) “Buy” Rating Reiterated at Canaccord Genuity Group - The AM Reporter

Mar 29, 2025

Mar 28, 2025

Earnings call transcript: TriSalus Life Sciences Q4 2024 sees 44% revenue growth - Investing.com India

Mar 28, 2025

Mar 28, 2025

TriSalus Life Sciences’ Q4 Loss Exceeds Projections, Revenue Tops Estimates – Retail Stays Pessimistic - Asianet Newsable

Mar 28, 2025

Mar 28, 2025

Trisalus outlines 50% revenue growth target for 2025 driven by TriNav expansion and new market penetration - MSN

Mar 28, 2025

Mar 28, 2025

TriSalus Life Sciences Reports Strong 2024 Growth - TipRanks

Mar 28, 2025

Mar 27, 2025

Earnings call transcript: TriSalus Life Sciences Q4 2024 sees 44% revenue growth By Investing.com - Investing.com South Africa

Mar 27, 2025

Mar 27, 2025

TriSalus Life Sciences Confirms Positive Outlook For FY25Update - Nasdaq

Mar 27, 2025

Mar 27, 2025

TriSalus Life Sciences Inc Reports Q4 Revenue of $8.3M, Exceedin - GuruFocus

Mar 27, 2025

Mar 27, 2025

TriSalus Life Sciences, Inc. Q4 Loss Decreases, But Misses Estimates - Nasdaq

Mar 27, 2025

Mar 27, 2025

TRISALUS LIFE SCIENCES Earnings Results: $TLSI Reports Quarterly Earnings - Nasdaq

Mar 27, 2025

Mar 27, 2025

TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update - Marketscreener.com

Mar 27, 2025

Mar 26, 2025

Examining the Future: TriSalus Life Sciences's Earnings Outlook - Benzinga

Mar 26, 2025

Mar 26, 2025

TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping - Marketscreener.com

Mar 26, 2025

Mar 26, 2025

Medicare Approves $11K+ Reimbursement for TriNav Cancer Treatment SystemMajor Win for Hospitals - Stock Titan

Mar 26, 2025

Mar 25, 2025

TRISALUS LIFE SCIENCES Earnings Preview: Recent $TLSI Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 25, 2025

Mar 22, 2025

TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System - Business Wire

Mar 22, 2025

Mar 20, 2025

TriSalus Life Sciences (TLSI) Projected to Post Earnings on Thursday - Defense World

Mar 20, 2025

Mar 18, 2025

TriSalus Life Sciences Announces CMS Reimbursement for the TriNav® Infusion System via Assignment of a New Technology Healthcare Common Procedure Coding System (HCPCS) Code - Business Wire

Mar 18, 2025

Mar 15, 2025

TriSalus Life Sciences (NASDAQ:TLSIW) Stock Price Down 10.7% – Here’s What Happened - Defense World

Mar 15, 2025

Mar 06, 2025

Can This Revolutionary Liver Cancer Treatment Double Drug Effectiveness? New Study Shows Remarkable Results - StockTitan

Mar 06, 2025

Mar 04, 2025

Short Interest in TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Expands By 75.3% - Defense World

Mar 04, 2025

Feb 28, 2025

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Feb 28, 2025

Feb 28, 2025

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives Average Recommendation of “Buy” from Analysts - Defense World

Feb 28, 2025

Feb 25, 2025

TriSalus Life Sciences announces executive departure By Investing.com - Investing.com South Africa

Feb 25, 2025

Feb 25, 2025

TriSalus Life Sciences announces executive departure - Investing.com India

Feb 25, 2025

Feb 24, 2025

3 Stocks With Robust Growth Outlooks Insiders Are Buying - MSN

Feb 24, 2025

Feb 19, 2025

Trisalus Life Sciences CFO buys $33,900 in common stock - MSN

Feb 19, 2025

Feb 19, 2025

Dated alert on Trisalus Life Sciences entering credit agreement withdrawn -February 19, 2025 at 08:04 am EST - Marketscreener.com

Feb 19, 2025

Feb 17, 2025

TriSalus Life Sciences (NASDAQ:TLSI) Now Covered by Analysts at Lake Street Capital - MarketBeat

Feb 17, 2025

Feb 15, 2025

TriSalus Life Sciences (NASDAQ:TLSI) Coverage Initiated at Lake Street Capital - Defense World

Feb 15, 2025

Feb 14, 2025

Lake Street Initiates Coverage of TriSalus Life Sciences (TLSI) with Buy Recommendation - Nasdaq

Feb 14, 2025

Feb 11, 2025

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) CFO Buys $33,900.00 in Stock - MarketBeat

Feb 11, 2025

Feb 10, 2025

Financial Comparison: TriSalus Life Sciences (NASDAQ:TLSI) versus Tenon Medical (NASDAQ:TNON) - Defense World

Feb 10, 2025